-
公开(公告)号:US20150079041A1
公开(公告)日:2015-03-19
申请号:US14493710
申请日:2014-09-23
IPC分类号: A61K35/74
CPC分类号: A61K35/745 , A61K35/747 , C12N1/20 , C12R1/01 , C12R1/225 , C12R1/23 , C12R1/25
摘要: The subject of the present invention is a bacterial composition having immunomodulation properties comprising at least one strain selected from the group consisting of Lactobacillus acidophilus PTA-4797, Lactobacillus plantarum PTA-4799, Lactobacillus salivarius PTA-4800, Lactobacillus paracasei PTA-4798, Bifidobacterium bifidum PTA-4801 and Bifidobacterium lactis PTA-4802. An other subject of the invention is an immunomodulation method comprising the step of using the at least one strain selected from the preceding group.
摘要翻译: 本发明的主题是具有免疫调节特性的细菌组合物,其包含选自嗜酸乳杆菌PTA-4797,植物乳杆菌PTA-4799,唾液乳杆菌PTA-4800,副干酪乳杆菌PTA-4798,双歧杆菌双歧杆菌 PTA-4801和乳酸双歧杆菌PTA-4802。 本发明的另一主题是免疫调节方法,其包括使用选自前述组的至少一种菌株的步骤。
-
公开(公告)号:US08071086B2
公开(公告)日:2011-12-06
申请号:US12778509
申请日:2010-05-12
CPC分类号: A61K35/745 , A61K35/747 , C12N1/20 , C12R1/01 , C12R1/225 , C12R1/23 , C12R1/25
摘要: The subject of the present invention is a bacterial composition having immunomodulation properties comprising at least one strain selected from the group consisting of Lactobacillus acidophilus PTA-4797, Lactobacillus plantarum PTA-4799, Lactobacillus salivarius PTA-4800, Lactobacillus paracasei PTA-4798, Bifidobacterium bifidum PTA-4801 and Bifidobacterium lactis PTA-4802. An other subject of the invention is an immunomodulation method comprising the step of using the at least one strain selected from the preceding group.
摘要翻译: 本发明的主题是具有免疫调节特性的细菌组合物,其包含选自嗜酸乳杆菌PTA-4797,植物乳杆菌PTA-4799,唾液乳杆菌PTA-4800,副干酪乳杆菌PTA-4798,双歧杆菌双歧杆菌 PTA-4801和乳酸双歧杆菌PTA-4802。 本发明的另一主题是免疫调节方法,其包括使用选自前述组的至少一种菌株的步骤。
-
公开(公告)号:US20100322964A1
公开(公告)日:2010-12-23
申请号:US12778509
申请日:2010-05-12
IPC分类号: A61K39/116 , A61K39/02 , A61P1/00 , A61P37/02 , A61P37/08 , A61P37/00 , A61P37/04 , C12N1/20 , A23L1/28 , A61K35/74
CPC分类号: A61K35/745 , A61K35/747 , C12N1/20 , C12R1/01 , C12R1/225 , C12R1/23 , C12R1/25
摘要: The subject of the present invention is a bacterial composition having immunomodulation properties comprising at least one strain selected from the group consisting of Lactobacillus acidophilus PTA-4797, Lactobacillus plantarum PTA-4799, Lactobacillus salivarius PTA-4800, Lactobacillus paracasei PTA-4798, Bifidobacterium bifidum PTA-4801 and Bifidobacterium lactis PTA-4802. An other subject of the invention is an immunomodulation method comprising the step of using the at least one strain selected from the preceding group.
摘要翻译: 本发明的主题是具有免疫调节特性的细菌组合物,其包含选自嗜酸乳杆菌PTA-4797,植物乳杆菌PTA-4799,唾液乳杆菌PTA-4800,副干酪乳杆菌PTA-4798,双歧杆菌双歧杆菌 PTA-4801和乳酸双歧杆菌PTA-4802。 本发明的另一主题是免疫调节方法,其包括使用选自前述组的至少一种菌株的步骤。
-
公开(公告)号:US07740838B2
公开(公告)日:2010-06-22
申请号:US11594543
申请日:2006-11-08
CPC分类号: A61K35/745 , A61K35/747 , C12N1/20 , C12R1/01 , C12R1/225 , C12R1/23 , C12R1/25
摘要: The subject of the present invention is a bacterial composition having immunomodulation properties comprising at least one strain selected from the group consisting of Lactobacillus acidophilus PTA-4797, Lactobacillus plantarum PTA-4799, Lactobacillus salivarius PTA-4800, Lactobacillus paracasei PTA-4798, Bifidobacterium bifidum PTA-4801 and Bifidobacterium lactis PTA-4802. An other subject of the invention is an immunomodulation method comprising the step of using the at least one strain selected from the preceding group.
摘要翻译: 本发明的主题是具有免疫调节特性的细菌组合物,其包含选自嗜酸乳杆菌PTA-4797,植物乳杆菌PTA-4799,唾液乳杆菌PTA-4800,副干酪乳杆菌PTA-4798,双歧杆菌双歧杆菌 PTA-4801和乳酸双歧杆菌PTA-4802。 本发明的另一主题是免疫调节方法,其包括使用选自前述组的至少一种菌株的步骤。
-
公开(公告)号:US07179460B2
公开(公告)日:2007-02-20
申请号:US10310549
申请日:2002-12-05
CPC分类号: C12R1/225 , A23L33/135 , A23Y2220/00 , A23Y2220/67 , A23Y2300/49 , A61K35/742 , A61K35/745 , A61K35/747 , C12N1/20 , C12R1/01 , C12R1/23 , C12R1/25 , Y10S435/822 , Y10S435/853 , Y10S435/854 , Y10S435/857
摘要: The subject of the present invention is a bacterial composition having immunomodulation properties comprising at least one strain selected from the group consisting of Lactobacillus acidophilus PTA-4797, Lactobacillus plantarum PTA-4799, Lactobacillus salivarius PTA-4800, Lactobacillus paracasei PTA-4798, Bifidobacterium bifidum PTA-4801 and Bifidobacterium lactis PTA-4802. An other subject of the invention is an immunomodulation method comprising the step of using the at least one strain selected from the preceding group.
-
公开(公告)号:US20070148148A1
公开(公告)日:2007-06-28
申请号:US11594543
申请日:2006-11-08
申请人: Veronique Dennin , Gregory Leyer , Annick Mercenier , Sophie Nutten , Bruno Pot
发明人: Veronique Dennin , Gregory Leyer , Annick Mercenier , Sophie Nutten , Bruno Pot
CPC分类号: A61K35/745 , A61K35/747 , C12N1/20 , C12R1/01 , C12R1/225 , C12R1/23 , C12R1/25
摘要: The subject of the present invention is a bacterial composition having immunomodulation properties comprising at least one strain selected from the group consisting of Lactobacillus acidophilus PTA-4797, Lactobacillus plantarum PTA-4799, Lactobacillus salivarius PTA-4800, Lactobacillus paracasei PTA-4798, Bifidobacterium bifidum PTA-4801 and Bifidobacterium lactis PTA-4802. An other subject of the invention is an immunomodulation method comprising the step of using the at least one strain selected from the preceding group.
-
公开(公告)号:US20070148147A1
公开(公告)日:2007-06-28
申请号:US11594542
申请日:2006-11-08
申请人: Veronique Dennin , Gregory Leyer , Annick Mercenier , Sophie Nutten , Bruno Pot
发明人: Veronique Dennin , Gregory Leyer , Annick Mercenier , Sophie Nutten , Bruno Pot
CPC分类号: A61K35/745 , A61K35/747 , C12N1/20 , C12R1/01 , C12R1/225 , C12R1/23 , C12R1/25
摘要: The subject of the present invention is a bacterial composition having immunomodulation properties comprising at least one strain selected from the group consisting of Lactobacillus acidophilus PTA-4797, Lactobacillus plantarum PTA-4799, Lactobacillus salivarius PTA-4800, Lactobacillus paracasei PTA-4798, Bifidobacterium bifidum PTA-4801 and Bifidobacterium lactis PTA-4802. An other subject of the invention is an immunomodulation method comprising the step of using the at least one strain selected from the preceding group.
摘要翻译: 本发明的主题是具有免疫调节特性的细菌组合物,其包含选自嗜酸乳杆菌PTA-4797,植物乳杆菌PTA-4799,唾液乳杆菌PTA-4800,副干酪乳杆菌PTA-4798,双歧杆菌双歧杆菌 PTA-4801和乳酸双歧杆菌PTA-4802。 本发明的另一主题是免疫调节方法,其包括使用选自前述组的至少一种菌株的步骤。
-
公开(公告)号:US20120135036A1
公开(公告)日:2012-05-31
申请号:US13283778
申请日:2011-10-28
CPC分类号: A61K35/745 , A61K35/747 , C12N1/20 , C12R1/01 , C12R1/225 , C12R1/23 , C12R1/25
摘要: The subject of the present invention is a bacterial composition having immunomodulation properties comprising at least one strain selected from the group consisting of Lactobacillus acidophilus PTA-4797, Lactobacillus plantarum PTA-4799, Lactobacillus salivarius PTA-4800, Lactobacillus paracasei PTA-4798, Bifidobacterium bifidum PTA-4801 and Bifidobacterium lactis PTA-4802. An other subject of the invention is an immunomodulation method comprising the step of using the at least one strain selected from the preceding group.
摘要翻译: 本发明的主题是具有免疫调节特性的细菌组合物,其包含选自嗜酸乳杆菌PTA-4797,植物乳杆菌PTA-4799,唾液乳杆菌PTA-4800,副干酪乳杆菌PTA-4798,双歧杆菌双歧杆菌 PTA-4801和乳酸双歧杆菌PTA-4802。 本发明的另一主题是免疫调节方法,其包括使用选自前述组的至少一种菌株的步骤。
-
公开(公告)号:US20100310513A1
公开(公告)日:2010-12-09
申请号:US12734238
申请日:2008-07-02
IPC分类号: A61K35/74 , C12N1/20 , C12N1/21 , A61P1/14 , A61P35/00 , A61P1/12 , A61P25/28 , A61P19/02 , A61P37/06 , A61P31/04 , A61P31/12 , A61P31/18 , A61P11/06 , A61P7/06 , A61P9/10 , A23C9/12
CPC分类号: C12R1/01 , A23C9/1234 , A23L33/135 , A23V2002/00 , A23Y2220/00 , A23V2200/3204 , A23V2200/32
摘要: New bacterium GC61 belonging to the genus Bifidobacterium, probiotic compositions comprising said bacterium, particularly food products, and use of said bacterium in the treatment of diseases, such as gastrointestinal diseases.
摘要翻译: 属于双歧杆菌属的新菌GC61,包含所述细菌的益生菌组合物,特别是食品,以及所述细菌在治疗胃肠道疾病等疾病中的应用。
-
公开(公告)号:US06579711B1
公开(公告)日:2003-06-17
申请号:US09548606
申请日:2000-04-13
申请人: Walter Gaier , David Pridmore , Francesca Stingele , Jean-Richard Neeser , Patrice Desachy , Bruno Pot
发明人: Walter Gaier , David Pridmore , Francesca Stingele , Jean-Richard Neeser , Patrice Desachy , Bruno Pot
IPC分类号: A01N6300
CPC分类号: C12R1/46 , C12P19/04 , Y10S435/883 , Y10S435/884
摘要: Strain of lactic acid bacterium, (1) whose 16S ribosomal RNA is characteristic of the genus Streptococcus, (2) whose total protein profile, obtained after migration of the total proteins on an SDS-PAGE electrophoresis gel, is characteristic of that of the strain of lactic acid bacterium CNCM I-1920 but distinct from those of the recognized species belonging to the genus Streptococcus, namely S. acidominimus, S. agalactiae, S. alactolyticus, S. anginosus, S. bovis, S. canis, S. caprinus, S. constellatus, S. cricetus, S. cristatus, S. difficile, S. downei, S. dysgalactiae ssp. dysgalactiae, S. dysgalactiae ssp. equisimilis, S. equi, S. equi ssp. equi, S. equi ssp. zooepidemicus, S. equinus, S. ferus, S. gallolyticus, S. gordonii, S. hyointestinalis, S. hyovaginalis, S. iniae, S. intermedius, S. intestinalis, S. macacae, S. mitis, S. mutans, S. oralis, S. parasanguinis, S. parauberis, S. phocae, S. pleomorphus, S. pneumoniae, S. porcinus, S. pyogenes, S. ratti, S. salivarius, S. sanguinis, S. shiloi, S. sobrinus, S. suis, S. thermophilus, S. thoraltensis, S. uberis, S. vestibularis, S. viridans. The invention also relates to the use of a strain of lactic acid bacterium according to the invention, or of a polysaccharide secreted by a strain according to the invention, for the preparation of a dietary composition, in particular an acidified milk or a fromage frais. The invention also relates to a dietary or pharmaceutical composition comprising a strain of lactic acid bacterium or a polysaccharide consisting of a succession of glucose, galactose and N-acetylglucosamine in a respective proportion of 3:2:1. In particular, strains CNCM I-1920, I-1921, I-1922, I-1923, I-1924, I-1925 and I-1926.
摘要翻译: 乳酸菌菌株,(1)其16S核糖体RNA是链球菌属的特征,(2)其在SDS-PAGE电泳凝胶上迁移总蛋白后获得的总蛋白质谱是该菌株的特征 的乳酸菌CNCM I-1920但不同于属于链球菌属的公认物种的那些,即S. acidominimus,无乳乳酸乳杆菌,解酒乳杆菌,血管梭菌,牛分枝杆菌,犬科,卡皮菌 ,S.stellatus,S.cricetus,S.cristatus,艰难梭菌,S.downei,S. dysgalactiae ssp。 白念珠菌,白念珠菌 马尾松,马尾松,马尾松 马 动物疫霉属,马氏足癣菌,马氏链球菌,半解葡萄球菌,戈氏杆菌,猪杆菌,猪链球菌,S.iniae,中间体,肠道肠杆菌,S. macacae,S.mitis,变异链球菌, 口腔is is,is,,is is,,,S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. S. 索氏梭菌,猪链球菌,嗜热链球菌,胸腺杆菌,乳房链球菌,前庭弓形虫,S. viridans。 本发明还涉及根据本发明的乳酸菌菌株或根据本发明的菌株分泌的多糖的用途,用于制备膳食组合物,特别是酸化牛奶或一种马铃薯。 本发明还涉及一种包含乳酸菌菌株或由一系列葡萄糖,半乳糖和N-乙酰葡糖胺组成的多糖的饮食或药物组合物,其比例为3:2:1。 特别是菌株CNCM I-1920,I-1921,I-1922,I-1923,I-1924,I-1925和I-1926。
-
-
-
-
-
-
-
-
-